ARTICLE SUMMARY:
Four experienced medtech investors offer their insights into the overall state of seed funding along with advice for medtech companies trying to land their first investments.
Despite the current uncertainty in the markets, investment is still available for medtech start-ups with capable, committed teams.
In a panel presentation titled “From Idea to Impact: Successfully Navigating Early-Stage Funding” at the recent MedTech Strategist Innovation Summit in Dublin, four European venture investors offered insights into the current funding environment for medtech companies as well as “dos and don’ts” for medtech entrepreneurs looking for seed-stage funding.
